In-Patient Trial of Liver Dialysis Succeeds

Researchers report that DIALIVE, a liver dialysis device invented at UCL's Institute for Liver and Digestive Health, was safe and effective in the first successful in-patient trial of liver dialysis. In a randomised, controlled trial of 32 patients with acute-on-chronic liver failure (ACLF), treated with DIALIVE or standard of care for up to five days, ACLF resolved in about twice as many DIALIVE patients. Dr Banwari Agarwal, the trial's chief investigator, said a larger trial is the next step, and the study was published in The Journal of Hepatology.